Illumina Accelerator invests in 7 genomics startups

By The Science Advisory Board staff writers

March 17, 2022 -- Illumina has invested in seven new genomics companies to join the fourth global funding cycle of Illumina Accelerator San Francisco Bay Area and Cambridge, U.K.

The latest investments included 4SR Biosciences, B4X, Cache DNA, CRISP-HR Therapeutics, NonExomics, Purpose Health, and Rethink Bio Private Limited. These startups focus on a variety of areas, including breakthrough therapeutics, diagnostics, DNA storage, mental wellness, and sustainable foods applications, according to the vendor.

Applications for the next global funding cycle are due by April 1. To learn more and apply, visit the accelerator site.


Copyright © 2022 scienceboard.net
 

Create an Account

Already have an account? Sign in Here

To access all ScienceBoard content create a free account now:



Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

 
I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.

Email Preferences



Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.